Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):3-8.
Natural regulatory anticoagulants proteins among Sudanese patients with dengue virus infection.
International journal of health sciences
Bashir Abdrhman Bashir, Osman Khalaf Allah Saeed
Affiliations
Affiliations
- Department of Hematology, Medical Laboratory Sciences Division, Port Sudan Ahlia College, Port Sudan, Sudan.
- Department of Internal Medicine, Faculty of Medicine, University of Gezira, Wad Madani, Sudan.
PMID: 28539856
PMCID: PMC5426412
Abstract
THE COAGULATION SYSTEM: Abnormalities in natural physiologic anticoagulants are observed in dengue infection. Laboratory values such as protein C (PC), protein S (PS), and antithrombin (AT) indicate this problem on the coagulation system in dengue. Recently, an interrelationship between dengue and the levels of natural anticoagulants has been observed.
OBJECTIVE: The study conducted to find out the effect of dengue on the natural anticoagulant proteins.
METHODS: A case-control study was conducted in Port Sudan Teaching Hospital from February 2013 to June 2014 for 334 cases of dengue caused by dengue virus, 217 (65%) males and 117 (35%) were females along with 101 cases of control 64 (63.4%) males and 37 (36.6%) were females. Laboratory-positive dengue cases were confirmed by immunoglobulin (Ig) M and IgG immune chromatography rapid test and the WHO criteria were used for classifying the dengue severity. Platelet count (PLT), plasma prothrombin time (PT), partial thromboplastin time (PTT), fibrinogen, D-dimer (DD), aspartate transaminase, alanine transaminase, PC, PS, and AT were performed.
RESULTS: Of 334, 289 patients had dengue fever (DF) and 45 patients had dengue hemorrhagic fever (DHF). Thrombocytopenia was present in 279 (83.5%). PLT was found to be significantly low in the case of dengue (
CONCLUSION: The findings of this study suggest that lower levels of these proteins in patients with dengue are attributed to disseminated intravascular coagulation.
Keywords: Antithrombin; D-dimer; Sudan; dengue; natural anticoagulants; protein C; protein S
References
- J Formos Med Assoc. 2013 Jan;112(1):12-7 - PubMed
- BMC Gastroenterol. 2010 May 07;10:43 - PubMed
- Thromb Haemost. 2001 Nov;86(5):1327-30 - PubMed
- Acta Med Indones. 2004 Apr-Jun;36(2):57-61 - PubMed
- Med J Armed Forces India. 2015 Jan;71(1):67-70 - PubMed
- Ann Acad Med Singapore. 2008 Jan;37(1):82-3 - PubMed
- J Infect. 2012 Mar;64(3):325-34 - PubMed
- J Infect Dev Ctries. 2012 Jul 23;6(7):551-4 - PubMed
- J Formos Med Assoc. 2012 Jun;111(6):297-9 - PubMed
- Thromb Haemost. 2007 Apr;97(4):627-34 - PubMed
- An Pediatr (Barc). 2006 Jun;64(6):523-9 - PubMed
- Am J Trop Med Hyg. 2009 Oct;81(4):638-44 - PubMed
- Semin Thromb Hemost. 1998;24(1):33-44 - PubMed
- Thromb Haemost. 2013 Aug;110(2):358-65 - PubMed
- BMC Infect Dis. 2013 Jul 28;13:350 - PubMed
- Clin Microbiol Rev. 1990 Oct;3(4):376-96 - PubMed
- J Ayub Med Coll Abbottabad. 2012 Jan-Mar;24(1):3-6 - PubMed
- Curr Hematol Rep. 2005 Mar;4(2):145-8 - PubMed
- Cytokine. 2011 May;54(2):222-31 - PubMed
- Clin Exp Immunol. 2004 Nov;138(2):299-303 - PubMed
- J Thromb Haemost. 2013 May;11(5):951-62 - PubMed
- J Assoc Physicians India. 2013 Jul;61(7):460-1 - PubMed
- Thromb Haemost. 2009 May;101(5):916-28 - PubMed
- Lancet Infect Dis. 2003 Jan;3(1):33-41 - PubMed
- Clin Infect Dis. 2002 Aug 1;35(3):277-85 - PubMed
- Am J Trop Med Hyg. 2001 Dec;65(6):840-7 - PubMed
- Blood Coagul Fibrinolysis. 2000 Jul;11(5):461-83 - PubMed
Publication Types